Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gottlieb Unleashed: Focus on Drug Pricing To Intensify As He Rejoins AEI

Apr 05 2019

• By Brenda Sandburg

FDA commissioner Scott Gottlieb

Related Content

Biosimilars Need Better Reimbursement, Not 'Kabuki' Coverage, Gottlieb Tells Insurers

Mar 08 2018

FDA's Gottlieb Applauds Drug Rebates At Point-Of-Sale

Mar 28 2018

Gottlieb Leaves FDA Feeling Good About Generic Approvals, But Concerned About Innovative Competition

Mar 28 2019

Drug Pricing Pundit Gottlieb Likely To Stay In His Lane At FDA

Apr 14 2017

FDA's Gottlieb: 'Pricing And Reimbursement Mischief' Holding Back Biosimilar Market

Mar 08 2018

Additional Topics

United States FDA Pricing Debate Policy Generic Drugs BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window